Vitamin D Supplementation in Acne

HITEC-Institute of Medical Sciences58 enrolled

Overview

The goal of this clinical trial is to compare in acne vulgaris patients. The main question it aims to answer is: • To assess the therapeutic benefit of vitamin D supplement in acne vulgaris treatment, following a 2-month treatment regimen that includes vitamin D supplementation compared to conventional (systemic azithromycin and topical retinoid) treatment alone. Participants will receive vitamin D supplements in addition to capsule Azithromycin and topical retinoid. Researchers will compare groups to determine efficacy of Vitamin D supplements in the treatment of Acne vulgaris.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Acne Vulgaris

Interventions

D Max DropsDIETARY_SUPPLEMENT

Vitamin D

Azithromycin 250 milligram Oral CapsuleDRUG

Anti Biotic

AdapaleneDRUG

Retinoid

Eligibility

Sex: ALLMin age: 13 YearsMax age: 40 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Individuals aged between 13 and 40 years with diagnoses of Acne vulgaris are included. Exclusion Criteria: * Individuals currently undergoing treatment for polycystic ovary syndrome (PCOs) * Those with obesity * Individuals employing vitamin supplementation * Those under the influence of topical or systemic steroids and acne treatment in the last 2 months.

Locations (1)

Hitec-Ims

Islamabad, Punjab Province, Pakistan

Outcomes

Primary Outcomes

Efficacious

Improvement in Global Acne Grading System Score from baseline to after 2 months of treatment

Time frame: 2 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.